Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels
- 31 March 2007
- Vol. 89 (3) , 362-369
- https://doi.org/10.1016/j.ygeno.2006.11.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levelsThrombosis and Haemostasis, 2006
- Angiotensin-Converting Enzyme Inhibition Increases Basal Vascular Tissue Plasminogen Activator Release in Women But Not in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Circadian Expression of Plasminogen Activator Inhibitor-1 in Angiotensin II Type 1a Receptor Knockout MiceClinical and Experimental Hypertension, 2005
- Genetics, statistics and human disease: analytical retooling for complexityTrends in Genetics, 2004
- Bradykinin Decreases Plasminogen Activator Inhibitor-1 Expression and Facilitates Matrix Degradation in the Renal Tubulointerstitium under Angiotensin-Converting Enzyme BlockadeJournal of the American Society of Nephrology, 2004
- The relationship between plasma t‐PA and PAI‐1 levels is dependent on epistatic effects of theACE I/DandPAI‐1 4G/5GpolymorphismsClinical Genetics, 2002
- Role of C/A Polymorphism at −20 on the Expression of Human Angiotensinogen GeneHypertension, 1999
- Polymorphism of Angiotensin Converting Enzyme Gene Is Associated With Circulating Levels of Plasminogen Activator Inhibitor-1Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Journal of Clinical Investigation, 1995
- No Adjustments Are Needed for Multiple ComparisonsEpidemiology, 1990